A Study to Assess the Safety and Tolerability of E2511 in Healthy Adult and Elderly Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

August 18, 2022

Study Completion Date

August 18, 2022

Conditions

Healthy Volunteers

Interventions

DRUG

E2511

E2511 tablets.

DRUG

Placebo

E2511 matched placebo tablets.

Trial Locations (1)

California Clinical Trials Medical Group, Glendale

All Listed Sponsors

lead

Eisai Inc.

INDUSTRY

NCT05147337 - A Study to Assess the Safety and Tolerability of E2511 in Healthy Adult and Elderly Participants | Biotech Hunter | Biotech Hunter